Durban 2000 to Toronto 2006: The evolving challenges in implementing AIDS treatment in Africa
Elimination of HIV-1 infection by treatment with a doxorubicin-conjugated anti-envelope antibody
An anti-HIV microbicide engineered in commensal bacteria: secretion of HIV-1 fusion inhibitors by lactobacilli
Antibodies to conserved epitopes of the HIV-1 envelope in sera from long-term non-progressors: prevalence and association with neutralizing activity
Reduced lopinavir exposure during pregnancy
Comparison of the risks of atherosclerotic events versus death from other causes associated with antiretroviral use
Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection
In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy
Peer referral for HIV case-finding among men who have sex with men
HIV-1 acquisition and disease progression are associated with decreased high-risk sexual behaviour among Kenyan female sex workers
‘Nothing new’: responses to the introduction of antiretroviral drugs in South Africa
Unexpected drug–drug interaction between tipranavir/ritonavir and enfuvirtide
Cardiac isoform of alpha 2 macroglobulin, an early diagnostic marker for cardiac manifestations in AIDS patients
Effects of infant sex on mother-to-child transmission of HIV-1 according to timing of infection in Zimbabwe
APOBEC3G genetic variants and their association with risk of HIV infection in highly exposed Caucasians
Response to ‘Atazanvir/ritonavir versus lopinavir/ritonavir: equivalent or different efficacy profiles?’ by Hill
Drugs should be affordable to India's poor to fight HIV/AIDS
Crohn's disease onset in an HIV/hepatitis C virus co-infected woman taking pegylated interferon α-2b plus ribavirin
The role of tenofovir in the prevention of HIV infections
Response to Waters et al. ‘Successful use of genotypic resistance testing in HIV-1-infected individuals with detectable viraemia …’